{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0007759/OMIM:144250","label":"Hyperlipidemia, familial combined, 3","mondoId":"MONDO:0007759","onsetQualifier":null,"recordKeys":["0b8e19350c14bf0f3c680b90276f5c115ad7209e3f63d3235c46f3719dde3354","545009f8ae0dcc591bd3f3266b1d9f535e1079ff446a9d274dcf6074bb530a0c","659f3d6519f2a0a39aa74638b628c53d92501c996522f644460f501703c0b6a2","7dcb403b7b8af067959f1d76994957546901cf7e02d2c9ca592919631c7b295a","c45090aac02ce75ab45d2ef0ddb2d72865bf9e7a18eec0ab6b65cce71a807fa6","cef0b5f13590672819b292c2e5db0297afd711c197ce2f33baebf9d5abe0abd7","d6ae70b61a4f0da26c3ad7b45f2a9ef02ceb772e7a99d2d71a62e376536e598b","f64d4fdb8f5c3614ea71f31c434b30072233e93bef484cbcc5d474649ca3ddd5"],"recordQualifiers":{},"scopeLabel":"OMIM:144250","sourceIds":["OMIM:144250"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0007759/OMIM:144250"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":8,"sourceGroups":{"omim":3,"orphanet":0,"published":5}},"features":[{"hpoId":"HP:0031800","label":"Elevated circulating apolipoprotein A-II concentration","primary":false},{"hpoId":"HP:0031798","label":"Elevated circulating apolipoprotein B concentration","primary":false},{"hpoId":"HP:0003141","label":"Elevated circulating LDL-C concentration","primary":false},{"hpoId":"HP:0003362","label":"Elevated circulating VLDL-C concentration","primary":false},{"hpoId":"HP:0003124","label":"Hypercholesterolemia","primary":false},{"hpoId":"HP:0003077","label":"Hyperlipidemia","primary":false},{"hpoId":"HP:0001658","label":"Myocardial infarction","primary":false},{"hpoId":"HP:0001114","label":"Xanthelasma","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0007759","records":[{"frequencyKind":"reported","key":"0b8e19350c14bf0f3c680b90276f5c115ad7209e3f63d3235c46f3719dde3354","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:144250","disease_name":"Hyperlipidemia, familial combined, 3","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0031798","is_excluded":false,"label":"Elevated circulating apolipoprotein B concentration","onset_id":null,"reference":"PMID:9373757","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"545009f8ae0dcc591bd3f3266b1d9f535e1079ff446a9d274dcf6074bb530a0c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:144250","disease_name":"Hyperlipidemia, familial combined, 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003077","is_excluded":false,"label":"Hyperlipidemia","onset_id":null,"reference":"OMIM:144250","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"659f3d6519f2a0a39aa74638b628c53d92501c996522f644460f501703c0b6a2","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:144250","disease_name":"Hyperlipidemia, familial combined, 3","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0031800","is_excluded":false,"label":"Elevated circulating apolipoprotein A-II concentration","onset_id":null,"reference":"PMID:12738753","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"7dcb403b7b8af067959f1d76994957546901cf7e02d2c9ca592919631c7b295a","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:144250","disease_name":"Hyperlipidemia, familial combined, 3","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001114","is_excluded":false,"label":"Xanthelasma","onset_id":null,"reference":"OMIM:144250","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"c45090aac02ce75ab45d2ef0ddb2d72865bf9e7a18eec0ab6b65cce71a807fa6","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:144250","disease_name":"Hyperlipidemia, familial combined, 3","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001658","is_excluded":false,"label":"Myocardial infarction","onset_id":null,"reference":"PMID:4718953","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"cef0b5f13590672819b292c2e5db0297afd711c197ce2f33baebf9d5abe0abd7","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:144250","disease_name":"Hyperlipidemia, familial combined, 3","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003141","is_excluded":false,"label":"Elevated circulating LDL-C concentration","onset_id":null,"reference":"PMID:4718953","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"d6ae70b61a4f0da26c3ad7b45f2a9ef02ceb772e7a99d2d71a62e376536e598b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:144250","disease_name":"Hyperlipidemia, familial combined, 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003124","is_excluded":false,"label":"Hypercholesterolemia","onset_id":null,"reference":"OMIM:144250","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"f64d4fdb8f5c3614ea71f31c434b30072233e93bef484cbcc5d474649ca3ddd5","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:144250","disease_name":"Hyperlipidemia, familial combined, 3","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003362","is_excluded":false,"label":"Elevated circulating VLDL-C concentration","onset_id":null,"reference":"PMID:4718953","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"hyperlipidemia-familial-combined-lpl-related","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"hyperlipidemia, familial combined, LPL related"},"schemaVersion":1}